Dr. Cosimo De Nunzio, a member of the European Association of Urology's Scientific Congress Committee, highlighted the VAPOUR trial results as a potential game-changer in urology. This trial is the first to compare medical therapy against minimally invasive treatments like water vapour therapy for urological conditions.
With aging populations across Europe, urological diseases such as LUTS, BPH, prostate cancer, and incontinence are expected to increase. Dr. De Nunzio emphasized the need for urologists to collaborate with healthcare authorities to optimize diagnostic and therapeutic strategies and manage rising costs of advanced treatments.
Artificial intelligence (AI) is poised to assist urologists in managing LUTS and BPH by analyzing patient data, bladder diaries, and urodynamic traces. While routine use and ethical considerations are still being addressed, AI is expected to enhance patient care significantly.
Biomarkers and advanced imaging, particularly in oncology, show promise for earlier disease progression identification. Integrating imaging, biomarker, and clinical data could help stratify risk, although their predictive power for conditions like BPO is still under evaluation.
International collaboration and clinical registries are fundamental for advancing BPH research globally, providing large, generalizable datasets. However, Dr. De Nunzio stressed that quality is determined by appropriate study design and topic selection, not just data volume.
The biggest unmet need in BPH management is the development of new pharmacological treatments with fewer adverse events, as the last significant drug introductions were over a decade ago. Patient perception and expectations also require more attention.
Dr. De Nunzio's career in urology was shaped by key mentors, including Giorgio Franco and C Chapple, who inspired his surgical aspirations and academic path. He advises early-career researchers to work diligently, follow their passion, invest in skills, and foster strong professional relationships.
For the next generation of urologists, adaptability is key. While robotic surgery attracts many, a broad understanding of various treatments, including non-surgical options, and collaboration with oncologists and radiotherapists will be crucial.